Table of content
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Clinical Trial Activity – Incidence & Growth (2023)
5.2 Equipment & Ancillary Solutions Demand, by Region (2023)
5.3 Clinical Trial Funding & Spending, by Region (Government, Commercial, Private, CROs) (2023)
5.4 Regulatory & Compliance Trends Affecting Market Growth (2023-2032)
5.5 Digital Transformation & Technological Advancements in Clinical Trial Equipment
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Service Benchmarking
6.3.1 Service specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Service launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Clinical Trial Equipment & Ancillary Solutions Market Segmentation, by Product
-
- Chapter Overview
7.2 Sourcing
7.2.1 Sourcing Market Trends Analysis (2020-2032)
7.2.2 Sourcing Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.3 Procurement
7.2.3.1 Procurement Market Trends Analysis (2020-2032)
7.2.3.2 Procurement Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.4 Rental
7.2.4.1 Rental Market Trends Analysis (2020-2032)
7.2.4.2 Rental Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Supply/Logistics
7.3.1 Supply/Logistics Market Trends Analysis (2020-2032)
7.3.2 Supply/Logistics Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.3 Transportation
7.3.3.1 Transportation Market Trends Analysis (2020-2032)
7.3.3.2 Transportation Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.4 Packaging
7.3.4.1 Packaging Market Trends Analysis (2020-2032)
7.3.4.2 Packaging Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.5 Others
7.3.5.1 Others Market Trends Analysis (2020-2032)
7.3.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Service
7.4.1 Service Market Trends Analysis (2020-2032)
7.4.2 Service Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4.3 Calibrations
7.4.3.1 Calibrations Market Trends Analysis (2020-2032)
7.4.3.2 Calibrations Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4.4 Equipment servicing
7.4.4.1 Equipment servicing Market Trends Analysis (2020-2032)
7.4.4.2 Equipment servicing Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4.5 Others
7.4.5.1 Others Market Trends Analysis (2020-2032)
7.4.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5 Others
7.5.1 Others Market Trends Analysis (2020-2032)
7.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Clinical Trial Equipment & Ancillary Solutions Market Segmentation, by Phase
-
- Chapter Overview
8.2 Phase I
8.2.1 Phase I Market Trends Analysis (2020-2032)
8.2.2 Phase I Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Phase II
8.3.1 Phase II Market Trends Analysis (2020-2032)
8.3.2 Phase II Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Phase III
8.4.1 Phase III Market Trends Analysis (2020-2032)
8.4.2 Phase III Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Phase IV
8.5.1 Phase IV Market Trends Analysis (2020-2032)
8.5.2 Phase IV Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.2.3 North America Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.4 North America Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.2.5 USA
9.2.5.1 USA Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.5.2 USA Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.2.6 Canada
9.2.6.1 Canada Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.6.2 Canada Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.2.7 Mexico
9.2.7.1 Mexico Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.7.2 Mexico Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Trends Analysis
9.3.1.2 Eastern Europe Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.1.3 Eastern Europe Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.4 Eastern Europe Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.1.5 Poland
9.3.1.5.1 Poland Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.5.2 Poland Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.1.6 Romania
9.3.1.6.1 Romania Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.6.2 Romania Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.1.7 Hungary
9.3.1.7.1 Hungary Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.7.2 Hungary Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.1.8 Turkey
9.3.1.8.1 Turkey Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.8.2 Turkey Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.1.9 Rest of Eastern Europe
9.3.1.9.1 Rest of Eastern Europe Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.9.2 Rest of Eastern Europe Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.2 Western Europe
9.3.2.1 Trends Analysis
9.3.2.2 Western Europe Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.2.3 Western Europe Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.4 Western Europe Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.2.5 Germany
9.3.2.5.1 Germany Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.5.2 Germany Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.2.6 France
9.3.2.6.1 France Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.6.2 France Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.2.7 UK
9.3.2.7.1 UK Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.7.2 UK Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.2.8 Italy
9.3.2.8.1 Italy Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.8.2 Italy Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.2.9 Spain
9.3.2.9.1 Spain Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.9.2 Spain Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.2.10 Netherlands
9.3.2.10.1 Netherlands Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.10.2 Netherlands Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.2.11 Switzerland
9.3.2.11.1 Switzerland Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.11.2 Switzerland Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.2.12 Austria
9.3.2.12.1 Austria Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.12.2 Austria Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.3.2.13 Rest of Western Europe
9.3.2.13.1 Rest of Western Europe Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.13.2 Rest of Western Europe Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.4.3 Asia Pacific Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.4 Asia Pacific Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.4.5 China
9.4.5.1 China Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.5.2 China Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.4.6 India
9.4.5.1 India Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.5.2 India Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.4.5 Japan
9.4.5.1 Japan Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.5.2 Japan Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.4.6 South Korea
9.4.6.1 South Korea Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.6.2 South Korea Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.4.7 Vietnam
9.4.7.1 Vietnam Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.7.2 Vietnam Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.4.8 Singapore
9.4.8.1 Singapore Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.8.2 Singapore Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.4.9 Australia
9.4.9.1 Australia Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.9.2 Australia Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.4.10 Rest of Asia Pacific
9.4.10.1 Rest of Asia Pacific Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.10.2 Rest of Asia Pacific Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.5 Middle East and Africa
9.5.1 Middle East
9.5.1.1 Trends Analysis
9.5.1.2 Middle East Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.1.3 Middle East Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.4 Middle East Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.5.1.5 UAE
9.5.1.5.1 UAE Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.5.2 UAE Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.5.1.6 Egypt
9.5.1.6.1 Egypt Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.6.2 Egypt Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.5.1.7 Saudi Arabia
9.5.1.7.1 Saudi Arabia Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.7.2 Saudi Arabia Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.5.1.8 Qatar
9.5.1.8.1 Qatar Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.8.2 Qatar Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.5.1.9 Rest of Middle East
9.5.1.9.1 Rest of Middle East Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.9.2 Rest of Middle East Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.5.2 Africa
9.5.2.1 Trends Analysis
9.5.2.2 Africa Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.2.3 Africa Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.2.4 Africa Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.5.2.5 South Africa
9.5.2.5.1 South Africa Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.2.5.2 South Africa Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.5.2.6 Nigeria
9.5.2.6.1 Nigeria Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.2.6.2 Nigeria Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.6.3 Latin America Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.4 Latin America Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.6.5 Brazil
9.6.5.1 Brazil Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.5.2 Brazil Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.6.6 Argentina
9.6.6.1 Argentina Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.6.2 Argentina Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.6.7 Colombia
9.6.7.1 Colombia Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.7.2 Colombia Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
9.6.8 Rest of Latin America
9.6.8.1 Rest of Latin America Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.8.2 Rest of Latin America Clinical Trial Equipment & Ancillary Solutions Market Estimates and Forecasts, by Phase (2020-2032) (USD Billion)
10. Company Profiles
10.1 Ancillare, LP
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Products/ Services Offered
10.1.4 SWOT Analysis
10.2 Imperial CRS, Inc.
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Products/ Services Offered
10.2.4 SWOT Analysis
10.3 Woodley Equipment Company Ltd.
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Products/ Services Offered
10.3.4 SWOT Analysis
10.4 Thermo Fisher Scientific, Inc.
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Products/ Services Offered
10.4.4 SWOT Analysis
10.5 Parexel International (MA) Corporation
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Products/ Services Offered
10.5.4 SWOT Analysis
10.6 Emsere (formerly MediCapital Rent)
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Products/ Services Offered
10.6.4 SWOT Analysis
10.7 Quipment SAS
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Products/ Services Offered
10.7.4 SWOT Analysis
10.8 IRM (International Resource Management)
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Products/ Services Offered
10.8.4 SWOT Analysis
10.9 Marken
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
10.10 Myonex
10.10.1 Company Overview
10.10.2 Financial
10.10.3 Products/ Services Offered
10.10.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
